Ravi Anand
Chief Tech/Sci/R&D Officer at NEWRON PHARMACEUTICALS S.P.A.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Luca Benatti | M | 63 | 26 years | |
| Stefan Weber | M | 60 | 12 years | |
| Patrick J. Langlois | M | 78 | 16 years | |
| Ulrich Köstlin | M | 71 | 11 years | |
| Roberto Galli | M | - | 22 years | |
| Filippo Moriggia | M | - | 8 years | |
| Dennis Dionne | M | - | 9 years | |
| Laura Faravelli | F | - | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marco Caremi | M | 67 | 21 years | |
| Ruggero Fariello | M | 81 | 8 years | |
| Rolf M. Zinkernagel | M | 80 | 15 years | |
| Giancarlo Mocchi | M | 84 | 3 years | |
| Bo Jesper Hansen | M | 66 | 5 years | |
| Joseph deBethizy | M | 74 | 9 years | |
| John A. Sedor | M | 80 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | 4 years |
| Robert Leslie Holland | M | 69 | 8 years | |
| Hervé Guérin | M | 82 | - | |
| Thomas McCourt | M | 66 | 7 years | |
| Xiu Cai Liu | M | 67 |
Sandoz Research Institute
| 3 years |
| Hanns Mohler | M | - | - | |
| Hans-Martin Blickensdoerfer | M | 59 | 2 years | |
| Ludwig Hantson | M | 61 | 9 years | |
| Krishan K. Arora | M | 83 | 5 years | |
| Philippe Weigerstorfer | M | 64 | - | |
| Ragnar Linder | M | 71 | - | |
| Marshall E. Reese | M | 78 | 5 years | |
| Enrique Carrazana | M | 62 | 9 years | |
| Frank Stiefel | M | - |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | - |
| Karim Hanna | M | - | 5 years | |
| Peter Maag | M | 56 | 1 years | |
| Hans van Eenennaam | M | - |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | 3 years |
| Diane Young | M | 68 |
Sandoz Research Institute
| 2 years |
| John Hohneker | M | 64 | 14 years | |
| Kevin Smith | M | - | 1 years | |
| Theresa Matkovits | M | 56 | 13 years | |
| Martin Cross | M | - | 2 years | |
| Guido Guidi | M | 71 |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | 12 years |
| Frédéric Guerard | M | 51 | 20 years | |
| Stefan Blarer | M | - | 10 years | |
| Stig Anders Lindberg | M | 52 | 1 years | |
| Renée Aguiar-Lucander | F | 62 | - | |
| Gilbert Wenzel | M | 67 | 3 years | |
| Deborah Dunsire | M | 61 | 4 years | |
| Sarah Boyce | F | 52 | 10 years | |
| William George | M | 81 | 10 years | |
| Rolf Stahel | M | 79 | 9 years | |
| Karen Hübscher | M | 61 | 6 years | |
| Francesco Parenti | M | 83 | 14 years | |
| Norman Walker | M | - | 5 years | |
| Thomas Ebeling | M | 65 | 7 years | |
| Argeris Karabelas | M | 71 | 2 years | |
| Axel Bolte | M | 52 | 3 years | |
| Johannes M. Respondek | M | 70 | 1 years | |
| Guy Rousseau | M | - | 6 years | |
| Joël Jean-Louis Besse | M | - | - | |
| Mihael Polymeropoulos | M | 64 | 5 years | |
| Roberto Consonni | M | - | - | |
| Hans-Joachim Lohrisch | M | 75 | - | |
| James New | M | 70 | 2 years | |
| Reinhard Ambros | M | 67 | 4 years | |
| Paolo Baroldi | M | 73 | 4 years | |
| Ryszard Wojtkowski | M | 68 | 3 years | |
| Frank Palantoni | M | 66 | 6 years | |
| Monique Mols | F | - |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | 5 years |
| Robert Jackson | M | - | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 34 | 52.31% |
| Italy | 25 | 38.46% |
| United States | 4 | 6.15% |
| Netherlands | 2 | 3.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ravi Anand
- Personal Network
